Funding models, economic and societal impact of pharmacy-based vaccination (Infographic)

Funding models, and economic and societal impact of pharmacy-based vaccination – Findings from FIP reports and literature

With an analysis of the funding models, economic value, and broader societal benefits of pharmacy-based vaccination (PBV) services worldwide, this report explores challenges to sustainable financing of PBV and highlights both direct and indirect savings generated through PBV, including improved immunisation coverage and reduced burden of vaccine-preventable diseases. It offers a comprehensive set of recommendations to guide policymakers, healthcare leaders and pharmacy stakeholders seeking to strengthen vaccination services through integrated, sustainable models.

An executive summary is also available here: https://lnkd.in/dy-DNhxm

Policy progress, stakeholder engagement and challenges in pharmacist-led vaccination: Findings from FIP reports and literature

This report highlights significant policy developments, the expanding role of pharmacists in improving immunisation access, and key challenges such as regulatory restrictions and professional resistance. It showcases best practices from leading countries, offering insights into effective strategies for broader implementation of pharmacist-administered vaccination.

It also serves as a resource for policymakers, healthcare professionals, and pharmacy organisations seeking to strengthen immunisation frameworks and integrate pharmacists into national vaccination strategies.

Empowering pharmacists to prevent HPV-related diseases and cancers and educate patients

HPV (Human Papillomavirus) is the most common sexually transmitted infection, affecting both men and women. It is linked to various cancers, including cervical, anal, oropharyngeal, penile, vaginal, and vulvar cancers. The HPV vaccine is a crucial tool in preventing these cancers and other HPV-related diseases. This digital event highlights the importance of the HPV vaccine, focusing on its safety and efficacy, and strategies to address common misconceptions. It also highlights practical tools that pharmacists can use to enhance patient education and increase vaccine uptake, contributing to increased awareness around HPV and the global effort to reduce HPV-related diseases and cancers.

Immunisation: Tackling hesitancy, expanding pharmacists’ roles, and proving impact

Worldwide, there is a significant expansion of pharmacists’ contribution to vaccination, as more countries are authorising pharmacists to deliver this healthcare and public health service. However, limited and inequitable access to vaccines in some countries, as well as vaccine misinformation and hesitancy, remain significant. This event explores strategies that can be useful in tackling vaccine hesitancy in communities, highlights the economic value of pharmacy-based vaccination to the healthcare system, and further advocates for extended pharmaceutical services in vaccination.

Pharmacy representation on national immunisation technical advisory groups (NITAGs)

Despite pharmacists’ role in providing accessible and evidence-based immunisation services to communities, their presence in advisory and decision-making roles on Vaccine Technical Committees, such as National Immunisation Technical Advisory Groups (NITAGs) and equivalent bodies, remains limited or underrepresented. This publication highlights the critical benefits of including pharmacists in these committees, explores the barriers preventing their involvement, identifies opportunities to enhance their representation, and outlines concrete strategies for engaging key stakeholders.

FIP knowledge and skills reference guide for professional development in vaccination services (2025)

This guide reinforces FIP’s commitment to supporting pharmacists in their role in vaccination. It builds on existing FIP data and resources to enhance pharmacists’ training and education in pharmacy-based vaccination. It outlines the key knowledge and skills that pharmacists need to meet the evolving demands of healthcare systems and public health needs, serving as a useful guide for practitioners, educators, students, and regulators.

Communication guide on HPV Vaccine and HPV-related diseases

This FIP communication guide supports pharmacists in starting conversations about human papillomavirus (HPV) vaccine & HPV-related diseases. The guide provides evidence-based information to address common concerns, promote HPV vaccination effectively, and raise awareness about cervical cancer.